Rationale for Use of Non–High-Density Lipoprotein Cholesterol Rather Than Low-Density Lipoprotein Cholesterol as a Tool for Lipoprotein Cholesterol Screening and Assessment of Risk and Therapy

This publication has 15 references indexed in Scilit:

• Cardiovascular disease burden increases, NIH funding decreases
  Nature Medicine, 1997
• Serum Lipids and Incidence of Coronary Heart Disease
  Circulation, 1996
• Management of Primary Hyperlipidemia
  New England Journal of Medicine, 1995
• Comparative Effects of Lovastatin and Niacin in Primary Hypercholesterolemia
  Archives of internal medicine (1960), 1994
• Postprandial hyperlipidemia and remnant lipoproteins
  Current Opinion in Lipidology, 1994
• McCollum Award Lecture, 1993: Triglyceride-rich lipoproteins and atherosclerosis—new perspectives
  The American Journal of Clinical Nutrition, 1994
• Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events.
  Circulation, 1993
• Calculated Low-Density Lipoprotein Cholesterol Should Not Be Used for Management of Lipoprotein Abnormalities in Patients With Diabetes Mellitus
  Diabetes Care, 1993
• 9 Hypertriglyceridaemia, triglyceride-rich lipoproteins and coronary heart disease
  Bailliere's Clinical Endocrinology and Metabolism, 1990
• Does measurement of apolipoprotein B have a place in cholesterol management?
  Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1990